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Abstract
Hypertension is a serious chronic condition that afflicts many Americans. The present
study used the Common Sense Model (CSM) of Self Regulation as a theoretical
framework to aid in the examination of predictors of medication and/or lifestyle
adherence. Based upon the literature reviewed, the current study proposes that predictors
would be different for medication and lifestyle adherence. Three hypotheses were
proposed: 1. CSM-related variables (blood pressure monitoring, condition-worry
hypertension duration, control beliefs, and medication beliefs items) would be correlated
with medication adherence; 2. specific CSM-related variables, self assessed health (SAH)
and physical functioning would significantly be correlated with lifestyle adherence; 3. If
there are common predictors of medication and lifestyle adherence, the predictors would
account for more of one type of adherence than the other. The current study utilized data
from a larger study evaluating patients’ management of acute and chronic conditions.
Results supported the three hypotheses. There was no correlation between medication and
lifestyle adherence. The overall model was significant in a stepwise regression with all
CSM-related predictors, including age, race and education predicting medication
adherence. The stepwise regression model was significant with all CSM-related
predictors, including, age, race and education predicting lifestyle adherence. Different
predictors in medication (the side effect of this treatment are manageable for me”) and
lifestyle adherence (“the prescribed treatment for my hypertension keeps it under good
control” were found supporting hypothesized independence of the two constructs.
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Introduction
Hypertension, commonly referred to as high blood pressure, is a serious chronic
illness that is pervasive in American society. One in three adults in the United States has
high blood pressure (American Heart Association, 2008), and epidemiological research
indicates that hypertension may affect 90% of individuals during their lifetime (Wand &
Vasan, 2005). It is also a condition which is very likely to be co-morbid with other
illnesses; in addition, it is a disease that has behavioral and physiological connections to
other health problems (American Heart Association, 2008). Individuals with hypertension
are at a greater risk than those without hypertension for renal failure, heart attacks, and
strokes (Wang & Vasan, 2005). Conversely, controlling hypertension has been shown to
reduce risk of stroke and congestive heart failure (Appel, Brands, Daniels, Karanja,
Elmer, & Sacks, 2006). As individuals age, the incidence of hypertension continues to
rise (65.4% of individuals 60 years of age or older (Hajjar & Kotchen, 2003).
Treatment of hypertension
The treatment of hypertension typically encompasses two approaches:
drug/medication therapy and lifestyle approaches (e.g. diet, exercise, and other). The goal
of treatment is often not to cure but instead to reduce blood pressure so that patients have
a lower possibility of developing complications. What is important to note is that clinical
recommendations for disease management is multi-faceted encompassing both
medication and lifestyle behaviors. The National Heart, Lung and Blood Association has
recommended that patients diagnosed with hypertension should work with their
physicians in developing individualized blood pressure goals through lifestyle and
medications regimens based upon individual risk factors. Lifestyle changes include
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exercise and healthier eating habits, such as diet, reduced sodium intake, reduced caloric
intake, and weight loss. Medication protocols for those with hypertension often include
one or more of a number of medicines such as alpha blockers, beta-blockers, calcium
channel blockers, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin
receptor blockers (ARBs), Central alpha agonists, diuretics, Renin inhibitors and
Vasodilators (High blood pressure treatment, lifestyle, medication, DASH diet. n.d.).
Adherence to hypertension treatment has however been problematic for many
patients (Meyer, Leventhal, & Gutmann, 1985). This can be attributed to hypertension
being a disease which is often asymptomatic and the treatments (especially medications)
may make patients feel worse than the disease itself (Morrell et al, 1997; Chapman,
Brewer, Coups, Leventhal, & Leventhal, 2001). While adherence may be difficult for
some, individuals who have been able to satisfactorily control their blood pressure
through a combination of a healthy lifestyle and medication have been able to, with
doctor supervision and monitoring, step down or even withdraw from medications. The
most successful at this endeavor are those individuals who have managed to maintain
lifestyle changes (e.g., lose weight, reduce sodium intake), those who have had mono
drug therapy (e.g., as opposed to combined medications) and those who have been able
to maintain lower systolic blood pressure over the course of multi-faceted treatment
(High blood pressure treatment, lifestyle, medication, DASH diet., n.d.).
Due to the scope and pervasiveness of hypertension it is a disease that has been
the subject of considerable research. In a community-based cross-sectional survey in
Ontario, Canada, 21% of individuals surveyed had hypertension (total adult population
was 7,996,653) (Fodor, Mclnnis, Helis, Turton, Frans, & Leenen, 2009). Fodor and
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colleagues (2009) found that 42% of hypertensive patients were on antihypertensive
medications and practiced lifestyle changes while 41% received drug therapy only.
Controlled blood pressure was found in 85% of those who only were on drug therapy and
78% of patients on the combination of drug and lifestyle treatments. There was not a
significant difference between blood pressure and treatment modality (medication only
versus medication plus lifestyle treatments). The researchers suggest that lifestyle
changes are disappointing in “real life” when comparing to medication treatment (p. 34).
An important limitation to this study was that self report was used to determine lifestyle
changes and medication adherence. Interestingly, less than half of the hypertension
patients who responded to the survey practiced lifestyle changes in addition to their
regular medications.
Although Fodor and colleagues (2006) suggest that the combination of
medication and lifestyle treatments are not as effective as medication alone, the limitation
of the study may point to why these results occurred. Moreover, the findings from Fodor
and colleagues contradict what is recommended by the National Heart, Lung and Blood
Institute (i.e. High blood pressure treatment, lifestyle, medication, DASH diet, n.d.)
which points out that it is important to look at hypertension treatment, in terms of both
drug therapy and lifestyle treatments. If practitioners, researchers, patients and other
stakeholders are to truly understand treatment regimens for high blood pressure, it is
critical to evaluate the extent to which medication and lifestyle adherence has been
studied in order to gain a comprehensive picture of how patients’ beliefs relate to
adherence. Research has looked at factors involved in medication adherence in
hypertensive patients (Haynes, Ackloo, Sahota, McDonald, Yao, 2008). Additionally,
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research has also looked at the factors involved in adherence to non-medication
treatments such as dietary regimens, exercise regimens, or physical therapy (lifestyle
treatments) (Whelton, Chin, Xin, & He, 2002). Research has investigated interventions
that address both medication and lifestyle adherence simultaneously in order to improve
blood pressure (Fahey, Schroeder, & Ebrahim, 2006). Due to the importance of lifestyle
and medication adherence concurrently, the evaluation of factors that relate to either
medication or lifestyle adherence is important.
Adherence to treatment for hypertension
There are a number of social factors that have been correlated with the incidence
and prevalence of hypertension. The rates of high blood pressure are alarmingly high
among African Americans, pursuant to the American Heart Association, almost one-third
(31.2%) of all African American adults have high blood pressure. As a result of these
elevated rates, researchers who look at adherence have sought to focus on culturally
appropriate interventions that may increase adherence to hypertension treatment
(medication and lifestyle changes). While taking into account cultural issues, Haafkens
and colleagues’ (2009) study protocol is useful because it aids in the understanding how
interventions address both medication and lifestyle adherence. Haafkens and colleagues
(2009) have developed a study protocol to address more specifically the disparities found
with individuals of African descent (in Europe) in controlling hypertension. The proposed
interventions compare the standard Dutch clinical guidelines to a culturally-appropriate
hypertension education in which elicitation and discussion of patients’ perceptions of
hypertension and treatment will be encouraged, however the findings from this proposed
program are not yet published. This study is important to note, not only because of the
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focus on cultural and race/ethnicity disparities, but because of its holistic approach to
hypertension treatment, and the inclusion of both medication and lifestyle change.
Expanding on this notion that the two types of treatments should be examined
together, the present study will look at factors/predictors involved in both medication and
lifestyle treatment adherence. As previously stated, simultaneous investigation is
important because adherence to both types of treatment is critical for controlling
hypertension. It is possible, for example, that some individuals adhere to one type of
treatment but not the other (e.g. Individuals who only take their medications and are non
adherent to their lifestyle changes); without simultaneous measurement of both types of
treatment, researchers will not be able to understand these individuals and the factors
involved in their behavior accurately. If medication and lifestyle treatment adherence are
distinct constructs, which factors determine one versus the other? If some patients are
adherent to both medication and lifestyle treatments, what makes these patients different
from patients who are non-adherent to either or both forms of treatment?
To begin, the important factors known to be involved in non-adherence to
medication and to lifestyle treatments will be reviewed before discussing how these
factors may be similar or different to each other and how they may interact to predict
adherence. Adherence rates are lower for chronic conditions, such as hypertension, than
for acute conditions (Osterberg & Blaschke, 2005). Patients who report missing any dose
of their medication for their chronic conditions are non-adherent 60% of the time
(Haynes, McDonald, & Garg, 2002). Thus, when a patient admits to missing any doses of
their medication, the health professional can be confident that they are missing more than
half the doses of the medication. Morrell and colleagues (1997) showed that 30-50% of
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hypertensive patients are non-adherent in taking their medications with some patients
taking less and some taking more of their medications than prescribed.
Other factors known to affect medication adherence include an individual’s age
(Morrell, Park, Kidder, & Martin, 1997), the asymptomatic nature of hypertension which
hinders the patient from being able to see improvement with treatment (Meyer,
Leventhal, & Gutmann, 1985), and the fact that the treatment can sometimes cause side
effects (Chapman, Brewer, Coups, Leventhal, & Leventhal, 2001). Conversely, a
positive predictor of medication adherence is how often the patient uses a blood-pressure
monitor which is additionally associated with more active self-care in general (Feldman,
Bacher, Campbell, Drover, & Chockalingam, 1998). The relationship of monitoring
behavior to medication adherence may be due to a general healthy lifestyle; alternatively,
the relationship between monitoring behavior and adherence may be specific to particular
medications and not related to lifestyle treatments. However, the question remains, do
those who monitor their hypertension also adhere to lifestyle treatments?
Low adherence is problematic not only when considering medication
management but also when considering lifestyle changes. It has proven to be challenging
for patients to stick to lifestyle treatments. Diet and exercise adherence have a
relationship with obesity and high blood pressure (Appel, Brands, Daniels, Karanja,
Elmer, & Sacks, 2006); therefore, adherence to diet and exercise can address
hypertension more fully than blood pressure medication alone. However, adherence to
diet and exercise regimen is poor (Leventhal, Dienfenbach, & Leventhal, 1992).
Many reasons for individuals not adhering to exercise and diet plans are well
documented and include intention-behavior gap, preference reversals, conservation of
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energy in the elderly, and ratings of self assessed health. More specifically, non
adherence to lifestyle treatments may be a result of the “gap” between individuals’
behavioral intentions and their actual behavior (“intention—behavior gap”; Sniehotta,
Scholz, & Schwarzer, 2005). Additionally, individuals reverse their preference for a
behavior when it comes time to perform it. For example, an individual may decide that
after indulging in an evening treat to run five miles the following day at 6 am. However,
when the alarm goes off, the individual reverses his/her preference (running) for the
snooze button. The above example demonstrates how challenging it is to effectively alter
one’s behavior (“preference reversals”; Bems, Laibson, & Loewenstein, 2007).
Specifically, with regard to elderly patients with hypertension, Duke and
colleagues (2002) found that patients may limit their activities above and beyond their
illness severity. A loss of activities was predicted by both chronic conditions, illness and
age severity. That is some patients reduce their activities beyond their physical
limitations which adversely affects their physical health. However, patients who had
social support, were optimistic and had less of a need to conserve energy were more
likely to replace lost activities. Leventhal and colleagues (1993) proposed that patients
who limit their activities may do so in order to conserve energy resources. Thus, when
considering the complexities underlining adherence to lifestyle treatments one should
consider an individual’s inclination to reverse their preference for a health behavior (diet
and/or exercise). Additionally, elderly patients may have a desire to decrease physical
activities as a function of needing to conserve energy.
Lower ratings of self-assessed health are predictive of less activity, and
individuals with hypertension and other chronic illness rate themselves lower in general
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health (Idler, Leventhal, McLaughlin, & Leventhal, 2004). Patients who are low in
physical functioning and/or who rate themselves low in general health may not be
adherent to their lifestyle regimen because of the need to conserve energy. However,
patients who are low in physical functioning and either unable or unwilling to adhere to
their lifestyle treatments may also not adhere to their medical treatment.
Research has looked at interventions that promote lifestyle modifications. Scala
and colleagues (2008) used a motivational approach compared to a control group to
control blood pressure, in a twelve month follow up study. The motivational group
(Intervention group) participated in a focus group at 2 months and 4 months post
recruitment. The control group received only oral information. Additionally, the control
group was called two and four months after recruitment so that the clinical staff could
obtain blood pressure, heart rate and weight in order to compare them with the
intervention group. Both groups had their blood pressure recorded and “drug therapy
registered” pre intervention and 12 months post intervention (p. 836). Although, this
study is not a direct assessment of medication adherence it suggests that assessing one’s
beliefs as they relate to lifestyle changes and being a part of a group increases lifestyle
modification and thus improves blood pressure.
The Common Sense Model of Health Beliefs and Behavior
The Common Sense Model (CSM) of health beliefs and behavior, first proposed
by Leventhal, is a useful theoretical framework that can support the investigation of
factors that influence adherence to medication and lifestyle treatments (Leventhal,
Dienfenbach, & Leventhal, 1992; Leventhal, Brissette, & Leventhal, 2003). The CSM is
a multidimensional framework that takes into account health beliefs, emotionality, and
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cognition, which aids in the understanding of patients’ health beliefs and behaviors and
has been applied to patients with varying chronic diseases (Hale, Trehame, & Kitas,
2007) including hypertension (Hekler, Lambert, Leventhal, Leventhal, Jahn, & Contrada,
2008; de Ridder, Theunissen, & van Dulmen, 2007). Patients develop illness
representations or “common sense” beliefs about their illness and treatment from both
abstract/factual (such as from the medical provider) and experience-based information
(such as changes in symptoms, e.g., with stress); the CSM places these beliefs into five
domains: identity, cause, duration, consequence, and cure.
Identity refers to the symptom experience and the name of the condition
(hypertension, flu, etc). Cause is what the patient believes to be the basis of the condition
(intemal/genetic and/or extemal/environmental causes). Timeline or duration connotes
the temporal expectation of the disease, simply how long one can expect to have the
condition (i.e. Will I have hypertension for the rest of my life?). Consequence is the
expected outcome of what the condition means (what the condition means for me in the
long term-1 must watch my salt and take medicine every day). Lastly, the cure domain
assesses patient’s beliefs whether the treatment regimens will alleviate the condition.
Patients’ illness representations or CSMs are fluid in that they change with new
information and new experiences, which in turn affect their health behaviors (for a review
see Ogden, 2000).
The CSM has been used as a theoretical framework in evaluating adherence in
hypertensive patients. Based upon abstract and factual/experiential information the CSM
has shown how patients’ manage their condition at different stages in treatment. More
specifically, Meyer and colleagues (1985) interviewed patients at different stages in their
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diagnosis of hypertension. 65% of the patients were only on a diuretic for their treatment,
60% of the patients were African American and 55% were female. Four groups were
interviewed. The first group served as a control because they were visiting the doctor for
a reason other than blood pressure (“normotensive clinic controls”). The second group
was labeled the “newly treated” group and was at the clinic for the first time for the
treatment of their hypertension. Third group, labeled “continuing treatment” had been in
continuous treatment from three months to fifteen years. Lastly, the “re-entry” group had
previously discontinued treatment and had returned to treatment. Patients’ beliefs were
elicited in a 45-minute structured interview and an open ended question to better
ascertain the patients’ beliefs compared to generally accepted views (what they thought
they should say). Results suggest that patients in the “new to treatment” group were more
likely to discontinue treatment if they indicated they experienced symptoms and told the
doctor on their first visit in addition to believing their hypertension to be an acute
condition. Patients in the “continuing treatment” group were more likely to stay in
treatment if they believed their symptoms to be controlled. These patients also were more
compliant to medication treatment and were more likely to have controlled blood
pressure.
Leventhal and colleagues have illustrated that common-sense beliefs are related to
medication adherence in hypertensive patients. Hekler and colleagues (2008)
demonstrated in a sample of African American patients with hypertension that there are
two prototypical common-sense models endorsed that affect patients’ adherence
behaviors. Endorsement of a “medical belief model” of hypertension showed that patients
believed the disease to be caused and controlled by diet, exercise, age, and weight. The
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second is the “stress belief model” in which patients endorse the belief that stress is the
main contributor (control and cause) of their hypertension. The stress belief model
demonstrates how the CSM has effectively identified a maladaptive strategy in
understanding one’s illness. While, chronic stress can be a contributing factor in the
cause of hypertension or exacerbate the illness, (American Institute of Stress, n.d.) it is
not the sole cause.
The notion that stress is a single cause has been shown to have important
consequences for patients’ adherence. This is demonstrated in Hekler et al (2008) who
found that endorsement of the “medical belief model” was associated with lower systolic
blood pressure and was mediated by lifestyle behaviors. Stress reduction was not
associated with systolic blood pressure. Endorsing the “stress belief model” led to
behaviors that decreased stress which did not lead to medication or lifestyle changes.
Heckler et al. (2008) also found evidence that CSM-related factors may predict different
kinds of adherence. Heckler and colleagues’ findings suggest that lifestyle and
medication adherence are different constructs and factors involved in each types of
adherence may be different from each other. It is here that the present study seeks to
expand the literature on hypertension treatment adherence and will explicitly evaluate the
extent to which medication adherence and lifestyle adherence are distinct constructs.
Additionally, this study will evaluate hypertension beliefs in a more representative
sample. Moreover, the current study will appraise the extent to which CSM beliefs are
associated to both lifestyle and medication adherence, respectively.
As previously stated, stress is not considered to be the sole cause of hypertension.
That is not to say developing effective coping skills to aid in the management of stress
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does not positively affect patient outcomes. Dusek and colleagues (2008) conducted a
double-blind, randomized trial comparing stress management to lifestyle modification.
The outcome variables were medication elimination and systolic blood pressure at eight
weeks. Results suggest that the stress management group led to more elimination of their
antihypertensive medication. Both groups had a reduction in systolic blood pressure,
however, patients in the stress management group were significantly more likely
eliminated antihypertensive medications The researchers address an important limitation
in the present study that the antihypertensive medications that patients reported being on
were not standardized. Thus patients who were on a certain type of medication may have
been able to eliminate said medication easier compared to a different type of medication.
Results point to the importance of providing patients with skills that will allow them to
cope with stress (i.e. mindful meditation, etc) and their chronic conditions while
effectively communicating the importance of lifestyle changes.
In understanding patient adherence, the evaluations of patient beliefs is critical.
Leventhal and Cameron (1987) proposed that adherence is a function of the patient’s
belief about their medication. They posit that a patient who believes he/she lacks control
over his/her illness will be less adherent because taking medication would have little
effect on his/her disease outcome. Treatment efficacy belief is a strong predictor of
adherence (DiMatteo, 2003).
As indicated above, the current study will look at both medication and lifestyle
adherence. Research has evaluated medication adherence and specific CSM-related
beliefs. Research has looked at CSM-related factor that may predict adherence based
upon Medical or Stress Belief Model (Hekler et al, 2008). I will expand upon this
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literature by further looking at functional limitations, self-assessed health, monitoring
behavior, and CSM-related beliefs (e.g., “I will have hypertension for the rest of my life”
and “The cause of my hypertension is clear to me”) as they relate to medication and
lifestyle treatment adherence. Factors related to medication and lifestyle treatment
adherence behaviors will be evaluated separately and compared to each other in order to
assess how the factors influence each type of adherence are related.
Based on the CSM model, three hypotheses have been formulated. The first
hypothesis is that the ten specific CSM-related variables (Appendix 1) will be
significantly related to medication adherence. The second hypothesis is specific CSMrelated variables (self assessed health and physical function) will be significantly related
to lifestyle adherence. Hypothesis three is that if there are common predictors to
medication and lifestyle adherence, the predictors will account for more of one type of
adherence versus the other. Due to the exploratory nature of this study, stepwise
regression will be done on all of the predictors including age, race, and education on the
criterion variables (lifestyle and medicine adherence) in separate analysis.

Methods
Participants and Recruitment
The present study is based on a larger study that was conducted between the summer
of 2007 to the winter of 2008 in an internal medicine primary care practice at a university
medical center. All patients who were seeing a physician in the primary care practice
were approached by research personnel regardless of their reason for seeing their doctor.
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Of those approached, 56 percent volunteered to participate and completed informed
consent forms. There were 402 patients who agreed to participate. Of the 402 patients
recruited for the larger study 129 were diagnosed with hypertension. 105 patients were
prescribed both medication and lifestyle regimens for their hypertension. Informed
consent and consent forms were completed and obtained prior to each patient’s doctor
visit. Patients who were recruited a second time were excluded.
The current study had 105 hypertensive patients with a mean age of 66.68 (table 2).
64.8% were female and 49.5% had less than or equal to a two year degree (associate
degree). 54.3% were retired and 28.6% were working full time. 37.5% had private health
insurance/HMO while 46.2% had Medicare with supplemental insurance. A majority of
the sample were married (69.5%) and white/European American (73.1%).
Measures
As part of the protocol for the larger study, the following variables of interest were
included in the current study: CSM-related beliefs including self-assessed health (SAH);
physical functioning; condition-worry, timeline, control belief, monitoring behavior, as
well as 4 medication belief items (“the prescribed treatment for my hypertension/high
blood pressure keeps it under control”, “I can actually feel the medicines working in my
body”, “the side effects of this treatment are manageable for me”, “I have a good idea of
how the medicines work”; and also lifestyle and medication adherence).
The predictor variables were SAH, physical functioning, condition-worry, timeline,
control beliefs, monitoring behavior, and the four CSM medication items. Criterion
variables were medication adherence and lifestyle adherence. Details describing all of
these measures are presented in Appendix 1.
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Criterion variables.

Both lifestyle and medication adherence were assessed using the Medication
Adherence Report Scale (MARS), (Thompson, Kulkami, & Sergejew, 2000). The
medication adherence question was: “Do you ever accidently forget to use one of your
medicines?”. This question was a Likert scale item with possible answer choices: never,
rarely, sometimes, often, or always. Lifestyle adherence was assessed using the item
worded: “Do you ever accidentally forget to do one of your other treatments (diet,
exercise, or others)?”. The scaling was the same as for Medication Adherence: “never”,
“rarely”, “sometimes”, “often”, and “always”.
Predictor variables.

Self-assessed health (SAH) was assessed by the item “In general, would you say your
health is...” with possible answer choices “poor,” “fair,” “good,” “very good,”
“excellent.” Physical functioning is a composite variable from patients’ responses to two
items from the Short Form 12 item survey (SF-12) (Ware, Kosinski, & Keller, 1996).
’’Does your health now limit you in moderate activities, such as moving a table, pushing a
vacuum cleaner, bowling, or playing golf?" and “Does your health now limit you in
climbing several flights of stairs?”. The possible answer choice to both items was: “yes,
limited a lot,” “yes, limited a little,” or “no, not limited at all.” A value of 1 was given to
“yes, limited a lot,” 2 was assigned to “yes, limited a little” and 3 was assigned to “no,
not limited at all.” The values were assigned to both items. The range of scores was
between 2 and 6, with higher numbers corresponding to higher level of physical
functioning (fewer limitations). (Appendix 1)
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Several other CSM-related belief items used in the current study were Likert scale
items (Appendix 1). Specifically, timeline belief was assessed using: “I will have HBP
for the rest of my life”; Control belief: “My HBP is under control most or all of the
time”; Condition-worry “How worried or concerned are you about you HBP?”. These
items had a possible answer choice of “not at all,” “a little bit,” “somewhat,” “quite a
bit,” or “very much.” Monitoring behavior was assessed with “How often do you use a
monitor or instrument to keep track of your Hypertension/High Blood Pressure?” and the
possible answer choices were “not at all,” “less than once a month,” “monthly,” “weekly
(1-2 times/week),” 2-3 times/week,” or “daily.”
Medication belief questions were: “The prescribed treatment for my
Hypertension/High Blood Pressure keeps it under good control,” “I can actually feel the
medicines working in my body,” “The side effects of this treatment are manageable for
me,” and “I have a good idea how the medicines work.” These items had a possible
answer choice of “not at all,” “a little bit,” “somewhat,” “quite a bit,” or “very much.”
Lastly, self-assessed health (SAH) was assessed by the item “In general, would you say
your health is...” with possible answer choices “poor,” “fair,” “good,” “very good,”
“excellent.”
Age and education are continuous variables. Race was defined as White/European
American and Minorities. This split was done because majority of the sample (73.1%)
identified themselves as White (Table 2). Education and age was defined in years.
Procedure
After the consent forms were completed, patients filled out a one-page questionnaire
while waiting to be called in for their appointment. Items that were assessed included the
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reason for the visit, self-assessed health (SAH), and what they expected from the doctor
visit. Patients separately consented to have their doctor visit audio-recorded. If the
patients did not consent to have their visit audio-recorded they were still included in the
study. After the patient was called into the physician’s office a questionnaire was given to
the physician that was to be filled out by the physician following the visit. The
physician’s questionnaire assessed patient’s health, illness progression, and prescribed
treatments. Patients were then contacted 24-48 hours after their doctor visit for a 1.5 to 2
hour phone interview. The interview consisted of assessment of doctor prescribed
treatment plans, physical and mental functioning, general health appraisals, and the
patient’s common-sense model beliefs. One month after the 24-48 hour interview patients
were contacted again by research personnel for a 30 minute phone interview. This phone
interview consisted of assessment about presenting problem resolution, physical and
mental functioning, general health assessment, and adherence to the presenting problem
prescribed treatments.
All research personnel interviewers went through training prior to recruiting and
interviewing. Additionally, interviewers had bi-weekly meetings to assess progress and to
keep up with the training and protocols.
Analysis overview
In order to explore the relationships between the predictor and criterion variables,
bivariate Pearson product moment correlations were computed for all 10 CSM related
variables and the two criteria measures.
The first two hypotheses (The first hypothesis is that the ten specific CSM-related
variables (Appendix 1) will be significantly related to medication adherence. The second
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hypothesis is specific CSM-related variables (self assessed health and physical function)
will be significantly related to lifestyle adherence.) were tested using bivariate Pearson
correlations using SPSS 16. The predictors and criteria used in the analyses are
continuous variables. A bivariate Pearson product-moment correlation coefficient was
computed to assess the relationship between the 10 CSM predictors (SAH, physical
functioning, monitoring; condition-worry; timeline; control belief; 4 medication belief
items) and medication adherence (Hypothesis one). Additionally, bivariate Pearson
product-moment correlation coefficients were computed to assess the relationship
between two predictors (self-assessed health (SAH) and physical functioning (specific
physical abilities)) and lifestyle adherence (Hypothesis two).
To further explore the relationship between the predictors and the criterion variables, two
separate stepwise regression analyses were conducted using all of the CSM-related
predictors (Appendix 1), plus age, race, and education. The criteria were medication
adherence and lifestyle adherence, respectively.
Expected results
Expected results are shown on Table 1 and are for the bivariate correlations
(hypotheses one and two). Plus sign (+) indicates a positive relationship. For example,
individuals who use a blood pressure cuff will be more likely to be adherence to their
medications. Since this is a preliminary analysis specific predictions on lifestyle
adherence are only made for SAH and physical functioning. The other predictors have a
question mark (?) indicating that there is no specific predictions made that can be
supported by the existing literature or CSM theory. The results for the subsequent
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analysis will depend on the findings of the bivariate analysis therefore no particular
results are expected.
Results
The results of the correlation analysis between CSM-related predictors and
medication adherence are presented in Table 3. A significant positive relationship was
shown between “The side effects of this treatment are manageable for me” and
medication adherence r(95) = .232, p<.05. As hypothesized, patients who indicated they
were able to manage the side effects of their treatments were more likely to adhere to
their medications. No other correlations were found to be significant (Table 3) with
medication adherence.
To test hypothesis two, Pearson correlation was used to examine the relationship
between SAH as well as physical functioning and lifestyle adherence (Table 3). A
significant positive correlation was shown between SAH and lifestyle adherence r (103)=
.222, p<.05. As hypothesized, patients who rated their health higher were more likely to
adhere to their lifestyle treatments. Contrary to hypothesis two, a significant relationship
was not found between physical functioning and lifestyle adherence r(103)= .024, p=.81.
In addition, two non-hypothesized relationships were found. A significant negative
relationship was revealed between condition-worry and lifestyle adherence r(102)= -.197,
p<.05. Patients who worry about their hypertension were less adherent to their lifestyle
treatments. Furthermore, a significant positive relationship was found between the
medication belief item, “The prescribed treatment for my Hypertension/High Blood
Pressure keeps it under good control” and lifestyle adherence r(101 )= .224, p<.05.
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Patients’ beliefs that their treatment keeps their hypertension under good control are more
likely to be adherent to lifestyle treatments.
Hypothesis three was tested by examining the pattern of correlations between the
10 CSM related predictors and the two outcome variables (see Table 3). These
correlations showed that there were four variables that predicted either medication or
lifestyle adherence. Only one of the medication belief items was significantly related to
medication adherence. The correlation between “side effects of this treatment are
manageable for me”, and medication adherence (r(95)= .232, p<.05) was significant. For
lifestyle adherence, Self-Assessed Health, condition-worry and one medication belief
item (“the prescribed treatment for my hypertension keeps it under good control”) were
significantly correlated (r(103)=.222, r=(102)= -.197, r=(101)=.224, respectively; p<.05
for all correlations). This pattern of results indicates that there are no shared predictors
between the 10 CSM beliefs and the two adherence variables. In addition, the pattern of
correlations for each of the adherence variables is different from one another.
Finally, Pearson product moment correlation was used to evaluate the relationship
between lifestyle and medication adherence. This analysis revealed that there is no
significant correlation between medication adherence and lifestyle adherence
r(103)=.056, p=.572.
Stepwise regression analysis was done with medication and lifestyle adherence as
the criterion, in separate analyses. Due to the exploratory nature of this analysis, all
predictors including age, race, and education were entered into a stepwise regression
simultaneously. Moreover, a less stringent alpha (.05-. 11) was set in order to allow the
predictors to account for more of the variance. Results indicate that the overall model was
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significant in predicting medication adherence F(l,76)=5.368, p<.05. A summary of the
regression coefficients are presented in table 4 and shows that only one item (“The side
effects of this treatment are manageable for me”) of the ten CSM-related predictors
significantly contributed to the model. This model accounts for 6.6% of the variance.
Table 4.1 shows the predictors that were not significant to the overall model. However,
physical function showed a trend toward significance, p=.057.
The same analysis (stepwise regression) was conducted with lifestyle adherence
as the criterion. The overall model was significant F(l,76)=4.707, p<.05 and accounted
for 5.8% of the variance. A summary of the regression coefficients are presented in table
5 and shows that one item (“The prescribed treatment for my hypertension keeps it under
good control”) out of the ten CSM-related predictors significantly contributed to the
model. Item, “I have a good idea of how the medicines work” showed a trend toward
significance, p=.059. Table 5.1 shows the predictors that were not significant to the
overall model.
Discussion
This study was designed to evaluate the relationship between CSM-related
predictors and medication as well as lifestyle adherence, respectively. Three hypotheses
were tested. Hypothesis one was not well supported by the significant correlation
between the predictor “The side effects of this treatment are manageable for me” and
medication adherence (Table 3). Monitoring behavior (using a blood pressure cuff),
physical functioning, condition-worry, hypertension duration beliefs, hypertension
control belief, in addition to the other medication belief items (“The prescribed treatment
for my Hypertension/High Blood Pressure keeps it under good control;” “I can actually
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feel the medicines working in my body;” “I have a good idea how the medicines work”)
did not correlate with medication adherence. There are a number of reasons why my
results were not supported which will be addressed in the limitations and further direction
section.
Hypothesis two was narrowly supported with a significant positive relationship
between SAH and lifestyle adherence. Contrary to my hypothesis, physical functioning
did not significantly correlate with lifestyle adherence. A significant negative relationship
was found between condition-worry and lifestyle adherence. Although this may be, on
initial reflection, counterintuitive, this correlation actually suggests that individuals who
do not adhere to their lifestyle treatments worry more about their hypertension. Patients
who do worry about their condition would presumably be more likely to adhere to both
medication and lifestyle treatments. Nevertheless, this relationship points to an interesting
issue, in so much that individuals who adhere to their prescribed medications but not their
lifestyle treatments may worry because they are cognizant of the discrepancy. Patients
may worry about their hypertension which may reflect non-adherence in both medication
and lifestyle adherence, although this is not supported by this study. Additionally,
lifestyle adherence is particularly low because of the required behavioral change which
many find to be a challenge for a variety of reasons including preference reversals and
intention-behavior gap (Bems, Laibson & Loewenstein, 2007 and Sniehotta, Scholz &
Schwarzer, 2005). Perhaps worrying about one’s condition is an extension that the patient
is mindful of the fact that they are not adhering to their lifestyle treatments.
A significant positive relationship was revealed between prescribed control-treatment
belief (“The prescribed treatment for my Hypertension/High Blood Pressure keeps it
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under good control”) and lifestyle adherence. That is patients who believe the prescribed
treatment keeps their hypertension under control are more likely to adhere to their
lifestyle treatments. This correlation makes sense when considering that treatment
efficacy belief is a strong predictor of adherence (DiMatteo, 2003). If a patient believes
the treatment is effective than they are more likely to adhere.
Medication and lifestyle adherence did not correlate with each other. This has
important implications for physicians. Patient adherence to medication or lifestyle
treatments do not predict adherence to the respective other type of treatment. As Haynes
et al (2005) demonstrates patients who admit to missing any dose of their medications for
their chronic conditions of their non-adherent 60% of the time. What does this look like
for patients in terms of lifestyle adherence? Further research is needed to tease out the
extent to which patients differ in their medication and lifestyle adherence. This has
important implications for physicians and health care providers as adherence between
medication and lifestyle are not related, based upon this study. Thus, if a patient adheres
to his/her medications, they may or may not be adherent to their lifestyle treatments.
The third hypothesis, which asserted that if there are common predictors to
medication and lifestyle adherence, the predictors would account for more of one type of
adherence versus the other was not confirmed. Since there were no shared predictors
between medication and lifestyle adherence, the hypothesis was supported lending
support that medication and lifestyle adherence predictors are distinct. What predicts one
type of adherence may not predict the other type of adherence. Further research
evaluating additional predictors would be useful. The current study still leaves open the
question that there may be shared predictors that were not assessed in the present study.
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Thus, there are in fact shared predictors between medication and lifestyle adherence that
were just not assessed.
In light of the fact that medication and lifestyle adherence did not correlate, the
two stepwise regression models also lend support that predictors for one type of
adherence may be different compared to the other type of adherence. Further research
should more explicitly evaluate the extent to which predictors are differentially related to
medication and lifestyle adherence. It would prove useful for physicians and health care
providers to be aware that not only is lifestyle and medication adherence different
constructs but predictors for one may be different than for the other type of adherence

As indicated above, this analysis used the CSM as a theoretical guide; however
another model that has had considerable attention in hypertension adherence research is
the Health Belief Model (HBM).
“The HBM is essentially a utility model. Its’ perspective on adherence is that
motivation emerges if an individual believes they are susceptible to a condition
and that the condition is severe. Thus, individuals are motivated to avoid a health
threat if the threat is believed likely (high probability of occurrence) and is seen to
have a negative impact on function or life itself (high severity). The specific
action selected depends upon its perceived benefits, access, likelihood of reducing
threat) and costs (actual financial cost; side effects; negative views of action by
family and friends, etc.). In addition, the concept of triggers to perceptions of
vulnerability and severity, e.g., symptoms, observation of illness in proximal
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others, etc., was added to HBM in 1957” (Rosenstock, Hochbaum & Leventhal,
I960 ) . 1
For additional review on the HBM please see Ogden (2007).
Middleton (2009) used the HBM framework and suggests that African
Americans do not adhere to hypertension treatments because the understandings of lay
beliefs diverge from the medical knowledge. For example, individuals believe they are
not susceptible and consider the condition to not be serious. As an extension of
Middelton’s (2009) work, Brown and Segal (1996) found that temporal-orientation has an
effect on HBM’s susceptibility and medication beliefs. More specifically, African
Americans compared to White Americans were more likely to be present-oriented which
affected management of hypertension. Present-oriented individuals compared to futureorientated individuals considered themselves to be less susceptible to the outcomes of
hypertension, believed in the efficacy of home remedies, and believed less in the efficacy
of prescription medications.
The HBM has also been used to exclusively evaluate medication adherence in
hypertensive patients. Hershey and colleagues (1980) used self-report to determine the
extent to which medication compliance was related to the HBM components. There was a
significant positive relationship with blood pressure and reported medication adherence
when compliance was dichotomized between reporting not missing a dose of their
medications and missing some of their pills. The researchers also found that three
(“control over health matters, perceived barriers, and duration of treatment”) of the five
1 The following section was prepared from a personal interview with H. Leventhal, an
originator of HBM and close associate and colleague of Rosenstock, Hochbaum and
Becker. (May 6, 2010)
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variables (“perceived severity and perceived benefits”) that contribute to the make up the
HBM relate to medication adherence, independently.
When considering the HBM and the CSM it is important to note that the HBM
and the CSM are not contradictions of one another. The CSM was developed as an
extension of the HBM.
“Both models consider patient beliefs as the driving force for behavior. However,
with the exception of the “triggers” concept the variables in HBM are highly
abstract (beliefs), stated as probabilities (likelihood of occurrence) and utilities
(severity) and attend less to the factors that underlie and represent the experiential
basis of these variables. The shift away from experience based perceptions
(perceived triggers, symptoms and observations of illness in others) and perceived
utilities (felt and observed changes in function, symptoms (pain) and cognitive
and social activities) to probability and severity judgments occurred as
investigators using HBM moved toward large scale survey research abandoning
open ended questions. This shift was subtle, a source of contention with the
original core of HBM investigators but solidified when the core empirical work
was taken in hand by Dr. Marshall Becker, a highly competent medical
sociologist. At a later date, HBM assimilated concepts from social learning
theory (self efficacy) to improve its predictive power. The differences between
HBM and CSM are primarily in the degree to which their measures focus on the
abstract aspect of representations of illness threats and treatments versus the
experiential basis of these abstractions, i.e., the perception, actual performance,
and perception of outcomes, HBM tending to focus on the abstract features and
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CSM on the experiential. The relative predictive power of these two levels of the
same constructs will vary by context, i.e., the illness (the degree to which it is
symptomatic and impacts function), the treatment and the patient population
2

(verbal/conceptual fluency versus grounded in everyday experience)”.

“cure in HBM is the belief that the disease is no more, cure in CSM means I no
longer experience the symptoms and dysfunction of the disease AND (because of
that) believe that the disease is gone.”
The hypotheses of this study were confirmed and the goal of the study was
attained, for it has provided a step toward much needed research that exclusively
evaluates the extent to which medication and lifestyle adherence are not related and
predictors for one are different from predictors for the other. This might affect patient
management of hypertension.
This study was intended to be a beginning in evaluating how hypertension
patients manage their chronic condition and to explicitly evaluate medication and
lifestyle adherence, which have been to shown to be important to hypertension
management (Appel et al., 2006). This study is however, exploratory and as such there
are a number of limitations which may account for the inconclusive findings. Taking into
consideration that this study was from a larger research project, the focus was on patient
2 The following section was prepared from a personal interview with H. Leventhal, an
originator of HBM and close associate and colleague of Rosenstock, Hochbaum and
Becker. (May 6,2010)
3The following section was prepared from a personal interview with H. Leventhal, an
originator of HBM and close associate and colleague of Rosenstock, Hochbaum and
Becker. (May 6, 2010)
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management and resolution of their (the patient’s) presenting complaint. Thus, patients
could have had any number of ailments that were the focus of the interview, therefore not
responding to the inquiries in terms of their hypertension. Additionally, the hypertension
questions were administered at the end of the interview and may have been subject to
patient fatigue. Finally, the sample size was relatively small. Many of the constructs
measured were assessed based upon single items which do not allow for generalizability
as well as meaningful interpretations.
In order to gain insight into how patients manage their hypertension it would be
ideal to have a study that exclusively researches hypertension management and the
evaluation of lifestyle as well as medication adherence as separate constructs. As
elaborated previously, medication adherence is particularly low when patients admit to
missing a single dose (60%) (Haynes, McDonald, & Garg, 2002). Additionally, lifestyle
adherence is low for a multitude of reasons including intention-behavior gap, preference
reversals, conservation of energy in the elderly, and ratings of self assessed health
(Sniehotta, Scholz, & Schwarzer, 2005; Bems, Laibson, & Loewenstein, 2007; Duke et
al., 2002; and Idler, Leventhal, McLaughlin, & Leventhal, 2004). In designing a better
study it would be imperative to have more items that assess the predictors as well as
lifestyle and medication adherence more fully. For example, it would be beneficial to
evaluate diet and exercise adherence separately. Perhaps the inconclusive findings in the
present study were a function of the combined item which was used to evaluate lifestyle
adherence (“Do you ever accidentally forget to do one of your other treatments (diet,
exercise, or others)?”). The evaluation of CSM-related predictors should have multiple
measures. For example, monitoring behavior has shown a positive relationship with
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medication adherence (Feldman et al., 1998). Our null results may be due in part because
of the single item that was used. It would be beneficial to use multiple items that assess
blood pressure monitoring including blood pressure from the doctor’s office and blood
pressure from those patients who do monitor themselves.
Additionally, a focus group of hypertension patients would be useful to add
qualitative data and to test the extent to which each item measures what is desired. In
order to more fully tap into patient’s adherence beliefs and behaviors it would be
beneficial to use the same items as Hekler and colleagues (2008) did. As Leventhal and
Cameron (1987) posit, a critical component in patient adherence is patient beliefs.
Additionally, the experiential factors are important to consider when evaluating
adherence. Assessing patients CSM beliefs can also assist health care providers and
doctors in understanding patient adherence. The evaluation of each CSM domain
(identity, consequence, cure, cause, and control) is important to explore especially as
each domain relates to medication and lifestyle adherence.
A useful instrument is the Illness Perception Questionnaire (IPQ-R) which was
derived from the CSM and addresses each of the five-domains (Moss-Morris R.,
Weinman J., Petrie K.J., Home R., Cameron L.D., & Buick D., 2002). Findings would
have theoretical relevance as well as applicability for physicians and health care
providers. Lastly, funding permitting, it would be beneficial to implement a longitudinal
design in order to evaluate the extent to which beliefs and behaviors change as related to
the CSM over time (Interpretation, Coping and Appraisal stage).
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Table 1
CSM predicted correlations for hypothesis one and two
Predicted correlations

Monitoring behavior
(use of blood pressure cuff)

Medication adherence
+

Lifestyle adherence
?

Self Assessed Health (SAH)

+

+

Condition-worry

+

?

Physical functioning

+

+

CSM Timeline belief

+

?

CSM control belief

+

?

+

?

I can actually feel the medicines
working in my body.

+

?

The side effects of this treatment
are manageable for me.

+

?

I have a good idea of how the
medicines work.

+

?

Medication beliefs:
The prescribed treatment
for my hypertension
keeps it under good control.
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Table 2
Characteristics of the Processes of Illness Management (PRIM) hypertension patients
Descriptives of hypertension patients (n=105)
Age (years), mean ± SD

66.68±12.06

Female (%)

64.8%

Education < 2 year university
degree (associate degree) (%)

49.5%

Employment

Retired: 54.3%
Working full time: 28.6%
Working part time: 7.9%
Disabled/on disability: 7.9%
Homemaker: 1.9%

Health insurance

Medicaid only: 1%
Medicare only: 6.7%
Private health/HMO: 37.5%
VA: 1%
Other insurance: 7.7%
Medicare w/supplemental insurance: 46.2%

Marital Status

Married: 69.5%
Divorced: 6.7%
Widowed: 15.2%
Single: 8.6%

Ethnicity

White: 73.1%
Black/African American: 19%
Asian/Pacific Islander: 2.9%
South Asian: 1%
Other: 3.8%
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Table 3
Pearson Correlation Coefficient of predictors and medication/lifestyle adherence
Comparisons between medication and lifestyle adherence
Predictors
(df)

Medication adherence (df)

Lifestyle adherence

Monitoring behavior

-.130(102)

.067(102)

Self Assessed health

-.014(103)

.222*(103)

Condition worry

-.168(102)

-.197*(102)

Physical functioning

.152(103)

.024(103)

Hypertension duration belief

.039(97)

-.059(97)

Hypertension control belief

.121(102)

.141(102

.021(101)

.224*(101)

I can actually feel the medicines
working in my body.

-.135(101)

.109(101)

The side effects of this treatment
are manageable for me.

.232*(95)

.053(95)

I have a good idea of how the
medicines work.

-.106(101)

.128(101)

Medication belief:
The prescribed treatment for my
Hypertension keeps it under good
control.

*p<.05
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Table 4
Estimated coefficients from OLS stepwise regression of medication adherence by patient
predictors from the Rutgers University PRIM study.
Standard
Model
statistic

Coefficient

“The side effects of this treatment are

-.205

Error

.088

Beta

t-

-.257 -2.317

manageable for me”

Constant

2.778*

Adj RA2

0.054

0.406

Source: Rutgers University, CSHBB PRIM study (2007-2008)
NOTE: N=77; Coefficient b =unstandardized regression coefficient. *p<.05

6.850
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Table 4.1
Estimated coefficients from OLS stepwise regression of medication adherence by patient
non- significant predictors from the Rutgers University PRIM study.

t-statistic

Sig

Beta

Age

1.113

.269

.123
-.018

00
1

Model

.875

Race

1.273

.207

.141

Monitor behavior

1.276

.206

.141

Self Rated Health

.662

.510

.074

Condition-worry

1.009

.316

.116

Physical Functioning

-1.936

.057

-.211

Duration hypertension belief

-.351

.727

-.039

Control hypertension belief

-.199

.843

-.024

“The prescribed treatment for my
Hypertension keeps it under good control”

.416

.678

.049

“I can actually feel the medicines working
in my body”

1.178

.243

.130

Education

“I have a good idea how the medicines work”.837
.405
.094
Source: Rutgers University, CSHBB PRIM study (2007-2008), NOTE: N=77; Beta In =
beta weight that would result if variable/item were entered back into the mode
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Table 5
Estimated coefficients from OLS stepwise regression of lifestyle adherence by patient
predictors from the Rutgers University PRIM study.
Standard
Model
statistic

Coefficient

Error

“The prescribed treatment for my

-.369

.170

Constant

4.274*

0.763

Adj RA2

0.046

Beta

t-

-.241

-2.170

hypertension keeps in under good control”

Source: Rutgers University, CSHBB PRIM study (2007-2008)
NOTE: N=77; Coefficient b =unstandardized regression coefficient. *p<.05

5.603
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Table 5.1
Estimated coefficients from OLS stepwise regression of lifestyle adherence by patient
non- significant predictors from the Rutgers University PRIM study.

Model

t-statistic

Sig

Beta In

Age

-1.412

.162

-.157

Education

1.527

.131

.170

Race

-.183

.855

-.021

Monitor behavior

-1.472

.145

-.163

Self Rated Health

-.790

.432

-.095

Condition-worry

.528

.599

.066

Physical Functioning

.798

.428

.093

Duration hypertension belief

.232

.817

.026

Control hypertension belief

.495

.622

.077

“I can actually feel the medicines working -1.661
in my body”

.101

-.184

“The side effects of this treatment are
manageable for me”

.692

.047

.059

-.211

00

I s*
H -k

“I have a good idea how the medicines work

.397

Source: Rutgers University, CSHBB PRIM study (2007-2008), NOTE: N=77; Beta In =
beta weight that would result if variable/item were entered back into the model.
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Appendix 1
CSM items from current study
Variable

Survey Question

Possible choices

Medication
adherence

“do you ever accidently forget to use one
of you medicines?”

“never,” “rarely,”
“sometimes,” “often”
or “always”

Lifestyle
adherence

“do you ever accidently forget to do one of your
other treatments (diet, exercise, or other)?

“never,” “rarely,”
“sometimes,” “often”
or “always”

Monitoring
Behavior

“how often do use a monitor or instrument
to keep track of your hypertension?

“not at all,” “less than
Once a month,”
“monthly,” “weekly
(1-2 times/week),” “2
-3 times/week,”
“daily”

Self Assessed
Health

“in general, would you say your health is:” “poor,” “fair,” “good”
“very good,”
“excellent”

Condition-worry

“how worried or concerned are you about
Your hypertension?”

Physical
Functioning

SF-12 composite of:
“does your health now limit you in moderate
activities, such as moving a table, pushing a
vacuum cleaner, bowling, or playing gold?”
“does your health now limit you in climbing
several flights of stairs?”

“yes, limited a lot,”
“yes, limited a little,”
“no, not limited at all”

CSM Beliefs “I will have hypertension for the rest of my life?

‘My hypertension is under control most or

“not at all,” “a little
bit,” “somewhat,”
“quite a bit,” or
“very much”

“not at all,” “ a little
bit," “somewhat,”
“quite a bit” or
“very much”
not at all,” “a little bit,”
somewhat,” “quite a bit,” or
very much”
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Appendix 1 (continued)
CSM items from current study
Survey Question

Variable
Medication belief

Possible choices

“the prescribed treatment for my hypertension
keeps it under good control”

“not at all,”
“a little bit”
“somewhat”
“quite a bit,”
“very much”

“I can actually feel the medicines working in
my body.”

“not at all,” “a little
bit,” “somewhat,”
“quite a bit,” or
“very much”

“the side effects of this treatment are
manageable for me.”

“not at all,” “a little
bit,” “somewhat”
“quite a bit,” or
“very much”

“I have a good idea of how the medicines
work.”

“not at all,” “ a little
bit,” “somewhat,”
“quite a bit,” or
“very much”

Age

What is your age?

Patient’s Age

Education

What is your highest degree from school?

Primary; High school;
Associate degree (2
Years); Bachelors
Degree (BA/BS)
Doctorate

Race

What race do you identify most with?

White, Black/Afiican
American, Asian/
Pacific Islander,
Other

